You have 9 free searches left this month | for more free features.

tamoxifen

Showing 1 - 25 of 142

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Duchenne Muscular Dystrophy Trial (Tamoxifen)

Completed
  • Duchenne Muscular Dystrophy
  • Tamoxifen
  • (no location specified)
Jul 21, 2022

Glioblastoma Multiforme Trial in Edmonton (Tamoxifen, Etoposide)

Recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 28, 2022

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting
  • Hypertension
  • +8 more
  • Tamoxifen
  • Placebo Oral Tablet
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 28, 2022

Infertility Trial in San Francisco (Tamoxifen, Letrozole)

Recruiting
  • Infertility
  • San Francisco, California
    University of California at San Francisco
Apr 29, 2022

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Dec 12, 2022

Vulvar Atrophy Trial in Adelaide, Nedlands (Tamoxifen, Placebo)

Recruiting
  • Vulvar Atrophy
  • Tamoxifen
  • Placebo
  • Adelaide, Southern Australia, Australia
  • +1 more
May 12, 2022

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Breast Cancer Trial in Milan (Tamoxifen, Placebo)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen
  • Placebo
  • Milan, Italy
    European Institute of Oncology
Aug 12, 2021

Ovarian Cancer Trial in Sydney (SUBA-itraconazole, Tamoxifen)

Not yet recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Dec 13, 2021

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Tamoxifen
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 13, 2021

Breast Cancer Trial in Singapore (Tamoxifen)

Recruiting
  • Breast Cancer
  • Tamoxifen
  • Singapore, Singapore
    National Cancer Centre
Jul 5, 2021

Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)

Not yet recruiting
  • Breast Cancer Female
  • All trans-retinoic acid
  • +6 more
  • (no location specified)
Aug 17, 2021

Breast Cancer Trial in Worldwide (GDC-0032, Tamoxifen)

Suspended
  • Breast Cancer
  • Paris, France
  • +13 more
Mar 21, 2022

Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

Completed
  • Breast Cancer
  • +2 more
  • Tamoxifen
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Breast Cancer Trial in New York (Fulvestrant, Tamoxifen)

Terminated
  • Breast Cancer
  • New York, New York
  • +2 more
Apr 27, 2021

Non Metastatic Breast Cancer Trial in Lyon, Paris, Saint Herblain (tamoxifen)

Completed
  • Non Metastatic Breast Cancer
  • tamoxifen
  • Lyon, France
  • +2 more
Mar 10, 2021

Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

Active, not recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +22 more
Apr 4, 2022

Early-stage Breast Cancer Trial (Cyclophosphamide, Methotrexate, Fluorouracil implant)

Completed
  • Early-stage Breast Cancer
  • (no location specified)
Oct 13, 2020

Breast Cancer Trial in Jakarta (Tamoxifen)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospitals Semanggi
Aug 12, 2022

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Tamoxifen
  • +3 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Breast Cancer Trial in Netherlands (Anastrozole, Anastrozole+Fulvestrant, Tamoxifen)

Suspended
  • Breast Cancer
  • den Haag, ZH, Netherlands
  • +3 more
Jan 20, 2021

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022